| Q37471676 | A clinical tool for predicting survival in ALS. |
| Q38808215 | A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS). |
| Q41637599 | A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland |
| Q53198631 | A population based study of respiratory function in motor neuron disease patients living in Tayside and North East Fife, Scotland. |
| Q40770831 | A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosis. |
| Q34104378 | A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? |
| Q39274964 | AJRCCM: 100-Year Anniversary. Homeward Bound: A Centenary of Home Mechanical Ventilation |
| Q28392297 | ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease |
| Q37650353 | ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis |
| Q58125262 | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration |
| Q27021917 | Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials |
| Q55877676 | Amyotrophic lateral sclerosis |
| Q56531746 | Amyotrophic lateral sclerosis |
| Q56531747 | Amyotrophic lateral sclerosis |
| Q59219368 | Amyotrophic lateral sclerosis |
| Q37590212 | Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever |
| Q30455100 | Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead |
| Q36202825 | Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole |
| Q34004742 | Amyotrophic lateral sclerosis. |
| Q37350223 | Amyotrophic lateral sclerosis: clinical management and research update |
| Q45138423 | Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation |
| Q57142256 | Amyotrophic lateral sclerosis: the complex path to precision medicine |
| Q36278310 | Amyotrophic lateral sclerosis: update and new developments. |
| Q92481952 | An observational study on quality of life and preferences to sustain life in locked-in state |
| Q39230744 | An unusual cause of ventilatory failure in motor neurone disease |
| Q35542017 | And the patient said: "let me be able to breathe and dream". |
| Q37235901 | Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? |
| Q90534110 | Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols |
| Q34518174 | BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults |
| Q53756131 | Bench evaluation of commercially available and newly developed interfaces for mouthpiece ventilation. |
| Q39278320 | Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes |
| Q64079969 | Biomarkers in Motor Neuron Disease: A State of the Art Review |
| Q38196863 | Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients |
| Q58567640 | Breathlessness in amyotrophic lateral sclerosis: A case report on the role of osteoporosis in the worsening of respiratory failure |
| Q53829177 | Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation. |
| Q94399934 | CIR-Myo News: Abstracts of the 2015 Spring Padua Muscle Days: Terme Euganee Padua (Italy), March 12-14, 2015 |
| Q87363904 | CIR-Myo News: Proceedings of the 2014 Spring Padua Muscle Days: Terme Euganee and Padova (Italy), April 3-5, 2014 |
| Q33867342 | Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent noninvasive ventilation in patients with ALS. |
| Q47725551 | Care Practices and Health-related Quality of Life for Individuals Receiving Assisted Ventilation. A Cross-National Study |
| Q34544295 | Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease. |
| Q48009568 | Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis |
| Q26783756 | Chronic hypoventilation syndromes and sleep-related hypoventilation |
| Q92016936 | Classifying Patients with Amyotrophic Lateral Sclerosis by Changes in FVC. A Group-based Trajectory Analysis |
| Q26738478 | Clinical Outcomes Associated with Home Mechanical Ventilation: A Systematic Review |
| Q55443790 | Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. |
| Q92579622 | Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis |
| Q36947727 | Clinical care of patients with amyotrophic lateral sclerosis |
| Q40572282 | Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation |
| Q37944429 | Clinical diagnosis and management of amyotrophic lateral sclerosis |
| Q86974848 | Clinical features and differential diagnosis of flail arm syndrome |
| Q36785984 | Clinical review: long-term noninvasive ventilation |
| Q36332191 | Comparison of exercise capacity in COPD and other etiologies of chronic respiratory failure requiring non-invasive mechanical ventilation at home: retrospective analysis of 1-year follow-up |
| Q44920842 | Compliance with home non-invasive ventilation |
| Q30365902 | Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. |
| Q58764899 | Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives |
| Q82603771 | Correction to our comment |
| Q47861613 | Correlation between Forced Vital Capacity and Slow Vital Capacity for the assessment of respiratory involvement in Amyotrophic Lateral Sclerosis: a prospective study |
| Q34041957 | Cryptorchism |
| Q92169247 | Current Status of Noninvasive Ventilation Use in Korean Intensive Care Units: A Prospective Multicenter Observational Study |
| Q29994759 | Decision-making and referral processes for patients with motor neurone disease: a qualitative study of GP experiences and evaluation of a new decision-support tool. |
| Q38689329 | Decision-making for tracheostomy in amyotrophic lateral sclerosis (ALS): a retrospective study |
| Q34182042 | Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need |
| Q38210852 | Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery |
| Q34010576 | Diagnosis and management of motor neurone disease |
| Q37193625 | Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis |
| Q38265872 | Diagnosis of muscle diseases presenting with early respiratory failure |
| Q28079469 | Diaphragm Dysfunction: Diagnostic Approaches and Management Strategies |
| Q28596787 | Diaphragm pacing and motor neurone disease: lessons for all? |
| Q48277253 | Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis |
| Q24188232 | Diaphragm pacing systems for amyotrophic lateral sclerosis / motor neuron disease |
| Q50041981 | Diaphragmatic Palsy |
| Q54563231 | Diaphragmatic pacing in amyotrophic lateral sclerosis. |
| Q49335981 | Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis |
| Q47719771 | Dissecting the benefits of long-term non-invasive ventilation in patients with distinct neuromuscular disorders |
| Q37931374 | EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force |
| Q97886198 | ERS International Congress, Madrid, 2019: highlights from the Sleep and Clinical Physiology Assembly |
| Q51439936 | Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial. |
| Q37140443 | Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency. |
| Q37241454 | Effects of non-invasive ventilation and posture on chest wall volumes and motion in patients with amyotrophic lateral sclerosis: a case series |
| Q40833671 | Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis |
| Q36695382 | Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis |
| Q39669650 | Effects of positive end expiratory pressure administration during non-invasive ventilation in patients affected by amyotrophic lateral sclerosis: A randomized crossover study |
| Q37867784 | Emerging targets and treatments in amyotrophic lateral sclerosis |
| Q47742878 | End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease |
| Q38366549 | End-of-life management in patients with amyotrophic lateral sclerosis |
| Q64061203 | Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis |
| Q47652467 | Evidence-based care in amyotrophic lateral sclerosis |
| Q46868258 | Experience of long-term use of non-invasive ventilation in motor neuron disease: an interpretative phenomenological analysis |
| Q90243724 | Experiences and views of patients, carers and healthcare professionals on using modems in domiciliary non-invasive ventilation (NIV): a qualitative study |
| Q39252157 | Factors predicting survival in ALS: a multicenter Italian study |
| Q39862319 | Factors predicting survival in amyotrophic lateral sclerosis patients on non-invasive ventilation |
| Q48266099 | Formal ventilation patient education for ALS predicts real-life choices |
| Q36892306 | Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group |
| Q46375687 | Have ALS centers changed the care and management of amyotrophic lateral sclerosis? |
| Q48747132 | Health-related quality of life among community-dwelling patients with intractable neurological diseases and their caregivers in Japan |
| Q36419791 | Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis |
| Q60911384 | Health-related quality of life as predictor for mortality in patients treated with long-term mechanical ventilation |
| Q38936982 | Home Mechanical Ventilation: An Overview |
| Q47876464 | Home mechanical ventilation for stable COPD in GOLD 2017: What are we ventilating? |
| Q35487734 | Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline |
| Q86066357 | Hypoventilation syndromes |
| Q58273127 | INSPIRATIonAL – INSPIRAtory muscle training in amyotrophic lateral sclerosis |
| Q39019894 | Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort |
| Q44775088 | Improved survival with an ambulatory model of non-invasive ventilation implementation in motor neuron disease. |
| Q83278118 | Improving survival in a large French ALS center cohort |
| Q51164588 | Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. |
| Q46947218 | Initiation of non-invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: Single-centre, retrospective, descriptive study in a national reference centre. |
| Q35058671 | Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice |
| Q58273441 | Is a four-hour use of non-invasive ventilation enough to define compliance? |
| Q39379700 | Is chronic ventilatory support really effective in patients with amyotrophic lateral sclerosis? |
| Q33719041 | Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients |
| Q34739073 | Is the effect of non-invasive ventilation on survival in amyotrophic lateral sclerosis age-dependent? |
| Q38013222 | Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients? |
| Q50708485 | Issues for palliative medicine doctors surrounding the withdrawal of non-invasive ventilation at the request of a patient with motor neurone disease: a scoping study. |
| Q37612320 | Life can be worth living in locked-in syndrome. |
| Q38238529 | Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis. |
| Q92347673 | Linear Accelerator-Based Radiotherapy Simulation Using On-Board Kilovoltage Cone-Beam Computed Tomography for 3-Dimensional Volumetric Planning and Rapid Treatment in the Palliative Setting |
| Q39008326 | Long-Term Mechanical Ventilation |
| Q35008199 | Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD |
| Q38166420 | Management of amyotrophic lateral sclerosis |
| Q37810000 | Management of respiratory symptoms in ALS |
| Q80852665 | Management of symptoms in amyotrophic lateral sclerosis |
| Q53178727 | Mandibuloptosis as a cause of supine choking in a patient with amyotrophic lateral sclerosis. |
| Q58787868 | Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives |
| Q37704865 | Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature |
| Q94326055 | Mechanical cough augmentation techniques in amyotrophic lateral sclerosis/motor neuron disease |
| Q35742650 | Mechanical insufflation-exsufflation: Practice patterns among respiratory therapists in Ontario |
| Q24199018 | Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease |
| Q24240593 | Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease |
| Q47677608 | Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. |
| Q37621814 | Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. |
| Q51653081 | Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis. |
| Q45869420 | Motoneuron Disease: Clinical |
| Q84028689 | Motor neuron disease: focusing the mind on ALS: updated practice parameters |
| Q37656842 | Motor neuron disease: systematic reviews of treatment for ALS and SMA. |
| Q39281105 | Motor neurone disease: a practical update on diagnosis and management |
| Q36117639 | Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies |
| Q35623262 | Multidisciplinary Interventions in Motor Neuron Disease |
| Q42649626 | NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. |
| Q28083435 | Neuromuscular disorders and sleep in critically ill patients |
| Q79431189 | Neuromuscular disorders: therapeutic advances |
| Q38580541 | Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature. |
| Q48497041 | Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests. |
| Q24187323 | Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders |
| Q24243245 | Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders |
| Q38157045 | Nocturnal non-invasive ventilation for cardio-respiratory disorders in adults |
| Q43465425 | Non-invasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis: spinal versus bulbar form |
| Q37972905 | Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. |
| Q54550128 | Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients. |
| Q45103099 | Non-invasive ventilation for Canadian patients with ALS: do we have consensus? |
| Q38071375 | Non-invasive ventilation in amyotrophic lateral sclerosis |
| Q59544336 | Non-invasive ventilation in amyotrophic lateral sclerosis |
| Q64923967 | Non-invasive ventilation in amyotrophic lateral sclerosis. |
| Q41887098 | Non-invasive ventilation with intelligent volume-assured pressure support versus pressure-controlled ventilation: effects on the respiratory event rate and sleep quality in COPD with chronic hypercapnia. |
| Q47686723 | Non-invasive ventilation: initiation and initial management |
| Q43860201 | Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy |
| Q38209844 | Noninvasive brain-computer interfaces for augmentative and alternative communication |
| Q37807689 | Noninvasive positive ventilation in the treatment of sleep-related breathing disorders |
| Q35542051 | Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study |
| Q47766295 | Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life |
| Q51848816 | Noninvasive ventilation in chronic respiratory failure: effects on quality of life. |
| Q35089202 | Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis |
| Q38764486 | Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia. |
| Q89942305 | Nursing care (palliative medicine) in patients with neuropsychiatric disorders |
| Q48098665 | Oral appliance to assist non-invasive ventilation in a patient with amyotrophic lateral sclerosis |
| Q39100323 | Oxygen therapy devices and portable ventilators for improved physical activity in daily life in patients with chronic respiratory disease. |
| Q35630224 | Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review |
| Q58124942 | Palliative care and circumstances of dying in German ALS patients using non‐invasive ventilation |
| Q64084307 | Palliative care for patients with motor neurone disease and their bereaved carers: a qualitative study |
| Q64960348 | Palliative care for patients with motor neurone disease: current challenges. |
| Q61812640 | Palliative care in motor neurone disease: where are we now? |
| Q48907916 | Palliative care in multiple sclerosis and motor neurone disease |
| Q22252562 | Palliative treatment of chronic neurologic disorders |
| Q26998579 | Patient-Perceived Outcomes and Quality of Life in ALS |
| Q37164599 | Patient-reported problematic symptoms in an ALS treatment trial. |
| Q47867801 | Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis |
| Q90449530 | Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation |
| Q57177809 | Patterns of Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis |
| Q46730298 | Perioperative care of palliative patients by the anesthetist : medical, psychosocial and ethical challenges |
| Q91814251 | Practical implementation of noninvasive ventilation in Amyotrophic Lateral Sclerosis: lessons learned from a clinical case series |
| Q38795064 | Practical respiratory management in amyotrophic lateral sclerosis: evidence, controversies and recent advances |
| Q37613342 | Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology |
| Q37250323 | Prognostic Value of Initial Assessment of Residual Hypoventilation Using Nocturnal Capnography in Mechanically Ventilated Neuromuscular Patients: A 5-Year Follow-up Study |
| Q36447824 | Prognostic factors in ALS: A critical review |
| Q43506498 | Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: a retrospective monocentre observational cohort study |
| Q42317993 | Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis? |
| Q34381673 | Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial. |
| Q39238445 | Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): a prospective population study |
| Q64102671 | Psychological flexibility and attitudes toward evidence-based interventions by amyotrophic lateral sclerosis patients |
| Q38099384 | Pulmonary issues in patients with chronic neuromuscular disease |
| Q48409417 | Qualify of life and palliation predict survival in patients with chronic alveolar hypoventilation and nocturnal ventilatory support |
| Q46383457 | Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology |
| Q27001213 | Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology |
| Q35008605 | Quantifying disease progression in amyotrophic lateral sclerosis |
| Q47745766 | Randomized cross-over trial of ventilator modes during non-invasive ventilation titration in amyotrophic lateral sclerosis |
| Q26749521 | Recent advances in amyotrophic lateral sclerosis |
| Q42273069 | Recent advances in the role of non-invasive ventilation in acute respiratory failure |
| Q39842138 | Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation |
| Q92716739 | Respiratory Involvement in Patients with Neuromuscular Diseases: A Narrative Review |
| Q37559615 | Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis |
| Q46636879 | Respiratory and nutritional support in amyotrophic lateral sclerosis |
| Q87302892 | Respiratory involvement in neuromuscular disease |
| Q90531342 | Respiratory management of patients with neuromuscular disease: current perspectives |
| Q38036088 | Respiratory therapies for amyotrophic lateral sclerosis: a primer |
| Q64086441 | Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials |
| Q24201081 | Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) |
| Q24246517 | Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) |
| Q39218942 | Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial |
| Q92909791 | Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis |
| Q47725074 | Sleep and Mechanical Ventilation in Stable COPD Patients. |
| Q37807706 | Sleep and breathing in neuromuscular disorders |
| Q49880538 | Sleep disordered breathing in motor neurone disease |
| Q35989539 | Sleep disordered breathing in spinal cord injury: A systematic review |
| Q37929127 | Sleep disturbance and neurological disease |
| Q93185685 | Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives |
| Q38365859 | Sleep-disordered Breathing in Neuromuscular Disease |
| Q37976297 | Sleep-disordered breathing in neurodegenerative diseases |
| Q47788130 | Sleepiness and Sleep-related Breathing Disorders in Myotonic Dystrophy and Responses to Treatment: A Prospective Cohort Study |
| Q37765293 | Some difficult decisions in ALS/MND. |
| Q34537070 | Supportive and symptomatic management of amyotrophic lateral sclerosis |
| Q34375695 | Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. |
| Q92236845 | Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in Spain: association with noninvasive mechanical ventilation |
| Q37272856 | Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis |
| Q38772250 | Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. |
| Q58153017 | THEME 4 RESPIRATORY AND NUTRITIONAL MANAGEMENT |
| Q48487078 | Tele-assistance in patients with amyotrophic lateral sclerosis: long term activity and costs |
| Q31143132 | Testing the SF-36 in Parkinson's disease. Implications for reporting rating scale data. |
| Q92497558 | The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea |
| Q64098266 | The Feasibility of Domiciliary Non-Invasive Mechanical Ventilation due to Chronic Respiratory Failure in Very Elderly Patients |
| Q92360470 | The Respiratory Phenotype of Rodent Models of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia |
| Q55398454 | The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALS. |
| Q39218891 | The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison |
| Q38449574 | The economic impact of amyotrophic lateral sclerosis: a systematic review. |
| Q37416385 | The frontotemporal syndrome of ALS is associated with poor survival |
| Q58244127 | The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy |
| Q44840792 | The influence of personality factors on disease progression and health-related quality of life in people with ALS. |
| Q48224143 | The initiation of non-invasive ventilation for patients with motor neuron disease: patient and carer perceptions of obstacles and outcomes |
| Q37395409 | The management of amyotrophic lateral sclerosis |
| Q38014082 | The natural history of motor neuron disease: assessing the impact of specialist care |
| Q64080931 | The pattern of use and survival outcomes of a dedicated adult Home Ventilation and Respiratory Support Service in Singapore: a 7-year retrospective observational cohort study |
| Q38661891 | The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis |
| Q53639814 | The predictors of survival in Chinese amyotrophic lateral sclerosis patients. |
| Q47677745 | The use of a hand held ventilator to supplement NIV for patients with ALS/MND with respiratory insufficiency |
| Q42594912 | The use of full-setting non-invasive ventilation in the home care of people with amyotrophic lateral sclerosis-motor neuron disease with end-stage respiratory muscle failure: a case series. |
| Q46360581 | The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences |
| Q56561503 | The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis |
| Q38631087 | The use of volume-assured pressure support noninvasive ventilation in acute and chronic respiratory failure: a practical guide and literature review |
| Q89932913 | The uses of overnight pulse oximetry |
| Q56970105 | Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications |
| Q24200285 | Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease |
| Q24241570 | Treatment for familial amyotrophic lateral sclerosis/motor neuron disease |
| Q39469418 | Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral |
| Q36773011 | Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy |
| Q40749038 | Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis |
| Q92280577 | Unstable control of breathing can lead to ineffective noninvasive ventilation in amyotrophic lateral sclerosis |
| Q26767357 | Update on clinical trials in home mechanical ventilation |
| Q38683234 | Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort |
| Q34360255 | Use of volume-targeted non-invasive bilevel positive airway pressure ventilation in a patient with amyotrophic lateral sclerosis |
| Q34523766 | Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study |
| Q60710006 | Validation of indirect calorimetry for measurement of energy expenditure in healthy volunteers undergoing pressure controlled non-invasive ventilation support |
| Q38088747 | What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease. |
| Q83813756 | Who benefits from home mechanical ventilation? |
| Q45357369 | Why don't they accept non-invasive ventilation?: insight into the interpersonal perspectives of patients with motor neurone disease |
| Q33886096 | Withdrawal of ventilation at the patient's request in MND: a retrospective exploration of the ethical and legal issues that have arisen for doctors in the UK |
| Q51521700 | Withdrawal of ventilation at the request of a patient with motor neurone disease: guidance for professionals. |
| Q39329860 | Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep |
| Q82728254 | [Catastrophic neuromuscular diseases] |
| Q79756685 | [When to use artificial respiration in amyotrophic lateral sclerosis?] |